Phylogenetic comparison of Epstein-Barr virus genomes
- PMID:29948828
- DOI: 10.1007/s12275-018-8039-x
Phylogenetic comparison of Epstein-Barr virus genomes
Abstract
Technologies used for genome analysis and whole genome sequencing are useful for us to understand genomic characterization and divergence. The Epstein-Barr virus (EBV) is an oncogenic virus that causes diverse diseases such as Burkitt's lymphoma (BL), nasopharyngeal carcinoma (NPC), Hodgkin's lymphoma (HL), and gastric carcinoma (GC). EBV genomes found in these diseases can be classified either by phases of EBV latency (type-I, -II, and -III latency) or types of EBNA2 sequence difference (type-I EBV, type-II EBV or EBV-1, EBV-2). EBV from EBV-transformed lymphoblastoid cell line (LCL) establishes type-III latency, EBV from NPC establishes type-II latency, and EBV from GC establishes type-I latency. However, other important factors play key roles in classifying numerous EBV strains because EBV genomes are highly diverse and not phylogenetically related to types of EBV-associated diseases. Herein, we first reviewed previous studies to describe molecular characteristics of EBV genomes. Then, using comparative and phylogenetic analyses, we phylogenetically analyzed molecular variations of EBV genomes and proteins. The review of previous studies and our phylogenetic analysis showed that EBV genomes and proteins were highly diverse regardless of types of EBV-associated diseases. Other factors should be considered in determining EBV taxonomy. This review will be helpful to understand complicated phylogenetic relationships of EBV genomes.
Keywords: Epstein-Barr virus; genomic variations; phylogenetic analysis.
Similar articles
- Determination and genome-wide analysis of Epstein-Barr virus (EBV) sequences in EBV-associated gastric carcinoma from Guangdong, an endemic area of nasopharyngeal carcinoma.Chen JN, Zhou L, Qiu XM, Yang RH, Liang J, Pan YH, Li HF, Peng GR, Shao CK.Chen JN, et al.J Med Microbiol. 2018 Nov;67(11):1614-1627. doi: 10.1099/jmm.0.000839. Epub 2018 Sep 21.J Med Microbiol. 2018.PMID:30239329
- Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.Lin N, Ku W, Song Y, Zhu J, Lu Z.Lin N, et al.Oncologist. 2019 Sep;24(9):e905-e913. doi: 10.1634/theoncologist.2017-0588. Epub 2019 Apr 2.Oncologist. 2019.PMID:30940744Free PMC article.
- Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection.Palser AL, Grayson NE, White RE, Corton C, Correia S, Ba Abdullah MM, Watson SJ, Cotten M, Arrand JR, Murray PG, Allday MJ, Rickinson AB, Young LS, Farrell PJ, Kellam P.Palser AL, et al.J Virol. 2015 May;89(10):5222-37. doi: 10.1128/JVI.03614-14. Epub 2015 Mar 18.J Virol. 2015.PMID:25787276Free PMC article.
- Epstein-Barr virus strains and variations: Geographic or disease-specific variants?Neves M, Marinho-Dias J, Ribeiro J, Sousa H.Neves M, et al.J Med Virol. 2017 Mar;89(3):373-387. doi: 10.1002/jmv.24633. Epub 2016 Dec 5.J Med Virol. 2017.PMID:27430663Review.
- Epstein-Barr Virus Strain Variation.Farrell PJ.Farrell PJ.Curr Top Microbiol Immunol. 2015;390(Pt 1):45-69. doi: 10.1007/978-3-319-22822-8_4.Curr Top Microbiol Immunol. 2015.PMID:26424643Review.
Cited by
- Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein-Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth.Wojtak K, Perales-Puchalt A, Weiner DB.Wojtak K, et al.Vaccines (Basel). 2019 May 24;7(2):44. doi: 10.3390/vaccines7020044.Vaccines (Basel). 2019.PMID:31137606Free PMC article.
- Stress-Induced Epstein-Barr Virus Reactivation.Sausen DG, Bhutta MS, Gallo ES, Dahari H, Borenstein R.Sausen DG, et al.Biomolecules. 2021 Sep 18;11(9):1380. doi: 10.3390/biom11091380.Biomolecules. 2021.PMID:34572593Free PMC article.Review.
- Aquaporin-3 is down-regulated by LMP1 in nasopharyngeal carcinoma cells to regulate cell migration and affect EBV latent infection.Li J, Shi D, Gong Z, Liu W, Zhang Y, Luo B.Li J, et al.Virus Genes. 2024 Oct;60(5):488-500. doi: 10.1007/s11262-024-02096-1. Epub 2024 Aug 5.Virus Genes. 2024.PMID:39103702
- F factor plasmid-mediated Epstein-Barr virus genome introduction establishes an EBV positive NPC cell model.Duan J, Yang Y, Wu Z, Lin S, Zhou C, Sheng G, Yang F, Bian L, Zhang X, Xiao S.Duan J, et al.Cancer Manag Res. 2019 Aug 5;11:7377-7389. doi: 10.2147/CMAR.S211372. eCollection 2019.Cancer Manag Res. 2019.PMID:31496799Free PMC article.
- A reliable Epstein-Barr Virus classification based on phylogenomic and population analyses.Zanella L, Riquelme I, Buchegger K, Abanto M, Ili C, Brebi P.Zanella L, et al.Sci Rep. 2019 Jul 8;9(1):9829. doi: 10.1038/s41598-019-45986-3.Sci Rep. 2019.PMID:31285478Free PMC article.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous